Answers are grounded in this paper and cite their sources.
Human hepatocyte transplantation is undergoing study as a bridge, or even alternative, to orthotopic liver transplantation (OLT). This technique has undergone multiple developments over the past thirty years in terms of mode of delivery, source and preparation of cell cultures, monitoring of graft function, and use of immunosuppression. Further refinements and improvements in these techniques will likely allow improved graft survival and function, granting patients higher yield from this technique and potentially significantly delaying need for OLT.
No takes yet. Share an insight, caveat, or question.
Heath et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: